Therapeutic potential of dual CDK12 and 13 inhibition in colorectal cancer

被引：0
|
作者：
Altunel, Erdem
Zokaasadi, Mohammad
Somarelli, Jason A.
McCall, Shannon J.
Gultawatvichai, Patan
Whalen, Giles Francis
Pitarresi, Jason
Hsu, David S.
机构：
[1] UMass Chan Med Sch, Div Hematol Oncol, Dept Med, Worcester, MA USA
[2] Duke Univ, Div Med Oncol, Dept Med, Med Ctr, Durham, NC USA
[3] Duke Univ, Dept Pathol, Med Ctr, Durham, NC USA
[4] UMass Chan Med Sch, Div Surg Oncol, Dept Surg, Worcester, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15601
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CDK12: a potential therapeutic target in cancer
    Emadi, Fatemeh
    Teo, Theodosia
    Rahaman, Muhammed H.
    Wang, Shudong
    DRUG DISCOVERY TODAY, 2020, 25 (12) : 2257 - 2267
  • [2] CDK12/13 inhibition in ovarian cancer cell lines
    Fiegl, H.
    Hovdar, L.
    Handle, F.
    Santer, F.
    Tsibulak, I
    Wieser, V
    Ausserlechner, M. J.
    Schnaiter, S.
    Zeimet, A. G.
    Marth, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (04) : 5 - 5
  • [3] Effects of CDK12/13 Inhibition in Patients with Ovarian Cancer
    Hovdar, L.
    Roessler, J.
    Hechenberger, P.
    Rainer, S.
    Ausserlechner, K.
    Greiderer-Kleinlercher, B.
    Ausserlechner, M.
    Marth, C.
    Zeimet, A. G.
    Fiegl, H.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (06) : E25 - E25
  • [4] Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
    Cheng, Lin
    Zhou, Shichao
    Zhou, Shaoqing
    Shi, Kaixuan
    Cheng, Yan
    Cai, Mei-Chun
    Ye, Kaiyan
    Lin, Lifeng
    Zhang, Zhenfeng
    Jia, Chenqiang
    Xiang, Huaijiang
    Zang, Jingyu
    Zhang, Meiying
    Yin, Xia
    Li, Ying
    Di, Wen
    Zhuang, Guanglei
    Tan, Li
    CANCER RESEARCH, 2022, 82 (19) : 3588 - 3602
  • [5] The promise and current status of CDK12/13 inhibition for the treatment of cancer
    Tadesse, Solomon
    Duckett, Derek R.
    Monastyrskyi, Andrii
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (02) : 117 - 141
  • [6] CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia
    Savoy, Lindsey
    Long, Nicola
    Lee, Hyunjung
    Chen, Reid
    Allen, Basil
    Lin, Hsin-Yun
    Tognon, Cristina
    Malhotra, Sanjay
    Tyner, Jeffrey W.
    Zhang, Haijiao
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 195 - 198
  • [7] CDK12: cellular functions and therapeutic potential of versatile player in cancer
    Pilarova, Kveta
    Herudek, Jan
    Blazek, Dalibor
    NAR CANCER, 2020, 2 (01):
  • [8] Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
    Quereda, Victor
    Bayle, Simon
    Vena, Francesca
    Frydman, Sylvia M.
    Monastyrskyi, Andrii
    Roush, William R.
    Duckett, Derek R.
    CANCER CELL, 2019, 36 (05) : 545 - +
  • [9] Characterisation of pharmacological phenotypes of CDK12/ 13 inhibition
    Jacob, K.
    Thomann, A.
    Weber, C.
    Gudennann, T.
    Peters, A.
    Zierfer, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S70 - S70
  • [10] CDK12: an emerging therapeutic target for cancer
    Lui, Goldie Y. L.
    Grandori, Carla
    Kemp, Christopher J.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) : 957 - 962
12345